Evidence map›Paper›PMID 41623168›Full record

ArticleThe Journal of clinical investigation2026

Targeting lymphatic vessels enhances bone regeneration by augmenting osteoclast activity in mouse models of amputation.

Neda Vishlaghi, Trisha K Ghotra, Monisha Mittal, Ji Hae L Choi, Sneha Korlakunta, Mingquan Yan, Janna L Crossley, Danielle Griswold-Wheeler, Elnaz Ghotbi, Conan Juan and 6 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. VEGF-D-induced intraosseous lymphangiogenesis drives site-specific heterotopic bone resorption.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Neda VishlaghiDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Trisha K GhotraDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Monisha MittalDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Ji Hae L ChoiDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Sneha KorlakuntaDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mingquan YanDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas, USA.
Janna L CrossleyDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Danielle Griswold-WheelerDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Elnaz GhotbiDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Conan JuanDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Shiri Gur-CohenDivision of Regenerative Medicine, UCSD, San Diego, California, USA.
Babak MehraraMemorial Hospital Research Laboratories, New York, New York, USA.
David A BrownDuke Cancer Institute, Durham, North Carolina, USA.
Michael T DellingerDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Lindsay A DawsonDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas, USA.
Benjamin LeviDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Funding

Targeting jmjd3 mitigates heterotopic ossificationR01AR079863 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Katherine Ann Gallagher, Benjamin Levi · 2021 to 2026
$3.0M
NIAMS NIH HHS R01 AR079863
6 · The paper itself

Abstract

Although mammals generally demonstrate limited regenerative capacity compared with amphibians, the digit tip retains remarkable regenerative potential, providing a useful model to study successful mammalian regeneration. This process involves coordinated immune cell activity, vascular remodeling, and tissue reconstruction, yet the molecular checkpoints controlling regenerative versus fibrotic outcomes remain poorly understood. In mammals, regeneration of the digit tip (P3) proceeds through myeloid cell migration, early osteoclast-mediated osteolysis of the distal bone, and subsequent blastema-mediated regeneration. Here we test the hypothesis that lymphatic vessels regulate regenerative capacity by modulating local immune cell dynamics and osteoclast function. Using a lymphatic system-specific reporter line, we discovered that lymphatic vessels grow toward the nail region from the ventral side of the digit during quiescence and after amputation. These lymphatics closely surround, but do not invade, the native or regenerated bone. Unexpectedly, genetic, pharmacological, and surgical inhibition of lymphangiogenesis accelerated early osteolysis through enhanced transition of myeloid cells to osteoclasts, resulting in faster and more robust regeneration. These findings reveal a mechanism linking lymphatic vessel, immune regulation, and bone remodeling, suggesting that targeted manipulation of lymphatics dynamics may enhance regenerative outcomes after musculoskeletal injury.

Indexed as

Amputation, SurgicalBone RegenerationLymphangiogenesisLymphatic VesselsOsteoclastsAnimalsMiceBone biologyOsteoclast/osteoblast biologyVascular biology

Identifiers

PMID41623168
PMCPMC12867134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.